Publications by authors named "Aarjith Damian Davis"

Article Synopsis
  • The rise in dementia, particularly Alzheimer’s disease (AD), necessitates a deeper understanding of its causes and treatments to enhance patient and caregiver quality of life.
  • AD’s pathophysiology involves the buildup of amyloid-beta plaques and tau protein abnormalities, leading to neurotransmitter imbalances that affect brain function.
  • FDA-approved treatments for AD can be divided into those addressing behavioral symptoms (like brexpiprazole for agitation) and cognitive decline (such as donepezil, a commonly prescribed cholinesterase inhibitor), each with specific mechanisms and side effects that require monitoring.
View Article and Find Full Text PDF